Lilly reports good results for brain-cancer drug

Eli Lilly reports its new cancer drug enzastaurin was able to shrink brain tumors in up to 25% of patients in a trial and stopped tumor growth in another 10%. The drug, which Lilly hopes to get to the market by 2008, cuts off drug supply to tumors and disrupts cell pathway signaling that is vital to tumor cells' survival.

View Full Article in:

Indianapolis Star (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC